Your browser doesn't support javascript.
loading
INFLIXIMAB and ADALIMUMAB in Uveitic Macular Edema.
Lejoyeux, R; Diwo, E; Vallet, H; Saadoun, D; Tezenas du Montcel, S; Bodaghi, B; LeHoang, P; Fardeau, C.
Afiliación
  • Lejoyeux R; a Ophthalmology Department, Reference Center for Rare Diseases OPTHARA, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
  • Diwo E; a Ophthalmology Department, Reference Center for Rare Diseases OPTHARA, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
  • Vallet H; b Department of Internal Medicine, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
  • Saadoun D; b Department of Internal Medicine, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
  • Tezenas du Montcel S; c Department of Biostatistics, Public Health and Medical Informatics, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
  • Bodaghi B; a Ophthalmology Department, Reference Center for Rare Diseases OPTHARA, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
  • LeHoang P; a Ophthalmology Department, Reference Center for Rare Diseases OPTHARA, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
  • Fardeau C; a Ophthalmology Department, Reference Center for Rare Diseases OPTHARA, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.
Ocul Immunol Inflamm ; 26(7): 991-996, 2018.
Article en En | MEDLINE | ID: mdl-30096013

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Uveítis / Edema Macular / Adalimumab / Infliximab / Antiinflamatorios Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ocul Immunol Inflamm Asunto de la revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Uveítis / Edema Macular / Adalimumab / Infliximab / Antiinflamatorios Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ocul Immunol Inflamm Asunto de la revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido